Population Pharmacokinetic Modeling and Simulation for Dose Optimization of GB-5001, a Long-Acting Intramuscular Injection of Donepezil, in Healthy Participants
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Population Pharmacokinetic Modeling and Simulation for Dose Optimization of GB-5001, a Long-Acting Intramuscular Injection of Donepezil, in Healthy Participants ; volume:13 ; number:5 ; day:10 ; month:8 ; year:2024 ; pages:1453-1466 ; date:10.2024
Neurology and Therapy ; 13, Heft 5 (10.8.2024), 1453-1466, 10.2024
- Classification
-
Medizin, Gesundheit
- Creator
-
Khwarg, Juyoung
Lee, Heeyong
Yu, Kyung-Sang
Seol, Eunyoung
Chung, Jae-Yong
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40120-024-00643-4
- URN
-
urn:nbn:de:101:1-2411262130167.470220818303
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Khwarg, Juyoung
- Lee, Heeyong
- Yu, Kyung-Sang
- Seol, Eunyoung
- Chung, Jae-Yong
- SpringerLink (Online service)
Other Objects (12)
Pharmacokinetics and Drug–Drug Interactions of Long-Acting Intramuscular Cabotegravir and Rilpivirine
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Long-Acting Reversible Contraception
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Development of long-acting ARV’s
Creation of a long-acting nanoformulated dolutegravir
A Network Meta-Analysis of Long-Acting Muscarinic Antagonist (LAMA) and Long-Acting β2-Agonist (LABA) Combinations in COPD
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling
Adolescents and Long-Acting Reversible Contraception: Lessons from Mexico
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Correction to: Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling
Pharmacokinetics and Drug–Drug Interactions of Long-Acting Intramuscular Cabotegravir and Rilpivirine
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Long-Acting Reversible Contraception
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Development of long-acting ARV’s
Creation of a long-acting nanoformulated dolutegravir
A Network Meta-Analysis of Long-Acting Muscarinic Antagonist (LAMA) and Long-Acting β2-Agonist (LABA) Combinations in COPD
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling
Adolescents and Long-Acting Reversible Contraception: Lessons from Mexico
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Correction to: Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling
Pharmacokinetics and Drug–Drug Interactions of Long-Acting Intramuscular Cabotegravir and Rilpivirine
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Long-Acting Reversible Contraception
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Development of long-acting ARV’s
Creation of a long-acting nanoformulated dolutegravir
A Network Meta-Analysis of Long-Acting Muscarinic Antagonist (LAMA) and Long-Acting β2-Agonist (LABA) Combinations in COPD
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling
Adolescents and Long-Acting Reversible Contraception: Lessons from Mexico
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia